Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Journal of Clinical Pharmacology
|
July 13, 2016
Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment
Henri Merdjan, Antoine Tarral, Shampa Das, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine
|
February 6, 2023
Antibody Responses of SARS-CoV-2 Vaccines amongst Health Care Workers in a Tertiary Care Hospital in Tripura, India: A Cross-Sectional Study
Chanda Mog, Sibabrata Bhattacharya, Subrata Baidya, et al.
Clinical Pharmacology in Drug Development
|
May 3, 2019
Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil
Jianguo Li, Shampa Das, Diansong Zhou, et al.
Journal of Clinical Pharmacology
|
October 24, 2013
Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam
Shampa Das, Jon Armstrong, David Mathews, et al.
Pharmacology Research & Perspectives
|
October 31, 2015
Randomized pharmacokinetic and drug-drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects
Shampa Das, Jianguo Li, Jon Armstrong, et al.
Journal of Clinical and Diagnostic Research : JCDR
|
April 8, 2017
A Study to Find Out the Full Immunization Coverage of 12 to 23-month old Children and Areas of Under-Performance using LQAS Technique in a Rural Area of Tripura
Anjan Datta, Subrata Baidya, Srabani Datta, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 25, 2012
Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis
James W T Yates, Shampa Das, Guy Mainwaring, et al.
Drugs in R&D
|
July 29, 2018
Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers
Richard Dimelow, James G Wright, Merran MacPherson, et al.
Diagnostic Microbiology and Infectious Disease
|
December 28, 2020
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models
Andrew Cristinacce, James G Wright, Merran Macpherson, et al.
Journal of Family Medicine and Primary Care
|
October 15, 2025
Socio-demographic and behavioural risk factors of SARS- CoV-2 seropositivity in rural tribal population of Tripura: A population based cross-sectional study
Subrata Baidya, Shampa Das, Biraj K Kalita, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Journal of Clinical Pharmacology
|
July 13, 2016
Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment
Henri Merdjan, Antoine Tarral, Shampa Das, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine
|
February 6, 2023
Antibody Responses of SARS-CoV-2 Vaccines amongst Health Care Workers in a Tertiary Care Hospital in Tripura, India: A Cross-Sectional Study
Chanda Mog, Sibabrata Bhattacharya, Subrata Baidya, et al.
Clinical Pharmacology in Drug Development
|
May 3, 2019
Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil
Jianguo Li, Shampa Das, Diansong Zhou, et al.
Journal of Clinical Pharmacology
|
October 24, 2013
Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam
Shampa Das, Jon Armstrong, David Mathews, et al.
Pharmacology Research & Perspectives
|
October 31, 2015
Randomized pharmacokinetic and drug-drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects
Shampa Das, Jianguo Li, Jon Armstrong, et al.
Journal of Clinical and Diagnostic Research : JCDR
|
April 8, 2017
A Study to Find Out the Full Immunization Coverage of 12 to 23-month old Children and Areas of Under-Performance using LQAS Technique in a Rural Area of Tripura
Anjan Datta, Subrata Baidya, Srabani Datta, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
September 25, 2012
Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsis
James W T Yates, Shampa Das, Guy Mainwaring, et al.
Drugs in R&D
|
July 29, 2018
Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers
Richard Dimelow, James G Wright, Merran MacPherson, et al.
Diagnostic Microbiology and Infectious Disease
|
December 28, 2020
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models
Andrew Cristinacce, James G Wright, Merran Macpherson, et al.
Journal of Family Medicine and Primary Care
|
October 15, 2025
Socio-demographic and behavioural risk factors of SARS- CoV-2 seropositivity in rural tribal population of Tripura: A population based cross-sectional study
Subrata Baidya, Shampa Das, Biraj K Kalita, et al.
Page
of 6